Showing results (31-40 of 35) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Cell Metabolism|March 10, 2016
A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic SubjectsSaswata Talukdar, Yingjiang Zhou, Dongmei Li, et al.Scientific Reports|April 27, 2021
Fc-GDF15 glyco-engineering and receptor binding affinity optimization for body weight regulationElla Fung, Liya Kang, Diana Sapashnik, et al.Scientific Reports|March 11, 2018
Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous DosingYan Weng, Tetsuya Ishino, Annette Sievers, et al.Journal of Medicinal Chemistry|June 8, 2018
Small Molecule Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: Hit to Lead Optimization of Systemic AgentsAllyn T Londregan, Liuqing Wei, Jun Xiao, et al.Angewandte Chemie (International Ed. in English)|October 27, 2017
Liver-Targeted Small-Molecule Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9 SynthesisKim F McClure, David W Piotrowski, Donna Petersen, et al.Pageof 4